“…The follow‐up period was variable with a mean duration of 1.2 years (Table 2). During the follow‐up, an improvement of GI symptoms, 28,35 weight and height gain, 19,22,24,29,31,36 resolution of anemia 18,21,22,27,29 and a reduction or disappearance of antibody titer 16,22,23,33,34 was reported. One patient died from sudden death 2 years after diagnosis 27 …”